![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/40 | (2006.01) |
C07D 403/04 | (2013.01) | ||
A61P 11/00 | (2006.01) | ||
A61P 11/00 | (2018.01) | ||
C07D 401/06 | (2013.01) | ||
A61P 37/06 | (2006.01) | ||
A61P 19/04 | (2018.01) | ||
A61P 17/00 | (2006.01) | ||
A61P 19/02 | (2006.01) | ||
A61K 31/455 | (2013.01) | ||
A61K 31/44 | (2006.01) | ||
A61K 31/506 | (2013.01) | ||
A61K 31/455 | (2006.01) | ||
A61P 19/02 | (2018.01) | ||
A61K 31/497 | (2006.01) | ||
A61P 37/06 | (2018.01) | ||
C07D 401/00 | (2006.01) | ||
A61K 31/4545 | (2013.01) | ||
C07D 401/06 | (2006.01) | ||
A61K 31/44 | (2013.01) | ||
C07D 403/04 | (2006.01) | ||
A61P 43/00 | (2018.01) | ||
A61K 31/4439 | (2006.01) | ||
A61P 17/00 | (2018.01) | ||
A61K 31/4545 | (2006.01) | ||
A61K 31/4439 | (2013.01) | ||
A61K 31/506 | (2006.01) | ||
A61K 31/40 | (2013.01) | ||
A61K 31/497 | (2013.01) |
(11) | Number of the document | 3277379 |
(13) | Kind of document | T |
(96) | European patent application number | 16714724.8 |
Date of filing the European patent application | 2016-03-29 | |
(97) | Date of publication of the European application | 2018-02-07 |
(45) | Date of publication and mention of the grant of the patent | 2021-12-08 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2016/024623 |
Date | 2016-03-29 |
(87) | Number | WO 2016/160755 |
Date | 2016-10-06 |
(30) | Number | Date | Country code |
201562140418 P | 2015-03-30 | US | |
201562183399 P | 2015-06-23 | US | |
201562252400 P | 2015-11-06 | US |
(72) |
LI, Zhe , US
HARRIS, Jason R. , US
DUFU, Kobina N. , US
GENG, Xin , US
SINHA, Uma , US
|
(73) |
Global Blood Therapeutics, Inc. ,
181 Oyster Point Blvd., South San Francisco, CA 94080,
US
|
(54) | ALDEHYDE COMPOUNDS FOR TREATING PULMONARY FIBROSIS, HYPOXIA, AND CONNECTIVE TISSUE AND AUTOIMMUNE DISEASE |
ALDEHYDE COMPOUNDS FOR TREATING PULMONARY FIBROSIS, HYPOXIA, AND CONNECTIVE TISSUE AND AUTOIMMUNE DISEASE |